Toggle Health Problems and D

Migraines in youths with low Vitamin D wonderfully treated by Vitamin D – June 2019

Evaluation of Vitamin D Levels and Response to Therapy of Childhood Migraine.

Medicina (Kaunas). 2019 Jun 28;55(7). pii: E321. doi: 10.3390/medicina55070321.
Kılıç B1, Kılıç M2.

  • 1 Dept of Child Neurology, University of Health Sciences, Derince Training and Research Hospital, 41900 Kocaeli, Turkey. betulklc82 at gmail.com.
  • 2 Dept of Neurosurgery, University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, 34371 Istanbul, Turkey. kilicnrs at gmail.com.

6 month trial on migraine youths of average age 13 who had < 20ng level of vitamin D
Started with 2,000 IU for 2 months, then 600 to 1,000 IU daily for 4 months

Expect that they would have had even better success by
Using larger dose sizes so as to get most of them >30 ng
  - Larger doses especially for those who were heavier/overweight
Adding Magnesium and Zinc
Also expect that the Migraines would have been reduced in a few weeks if they had used a loading dose of Vitamin D

Note: Both Migraines and Cluster headaches in adults have been very succesfully treated by Vitamin D and Magnesium

See also VitaminDWiki

Headache category has the following

Metal MigraineNo Migraine Ratio
Cadmium 0.36 ug0.09 ug 4X MORE if decrease
Iron0.97 ug0.48 ug2X MORE if decrease
Lead1.48 ug0.78 ug 2X MORE if decrease
Magnesium10.6 ug34.5 ug 3.5X LESS if increase
Zinc0.24 ug 5.77 ug 24X LESS if increase

Pages listed in BOTH the categories Headache and Magnesium

 Download the PDF from VitaminDWiki


Vitamin D deficiency and insufficiency are related with many neurological diseases such as migraine. The aim of this study was to investigate whether pediatric migraine is associated with vitamin D deficiency and the effect of vitamin D therapy on the frequency, duration, severity of migraine attacks, and Pediatric Migraine Disability Assessment (PedMIDAS).

We retrospectively examined the patients' levels of calcium, phosphorus, parathyroid hormone, alkaline phosphatase, and 25-OH vitamin D of 92 pediatric migraine patients. The patients were divided into two groups: Group 1, which had low vitamin D levels and received vitamin D therapy, and group 2, which had normal vitamin D levels and did not receive vitamin D therapy. Migraine severity measured by the visual analog scale (VAS), migraine frequency, and duration as well as scores on the PedMIDAS questionnaire were compared with regard to the 25-OH vitamin D levels. In addition, pre- and posttreatment pedMIDAS scores, VAS, migraine frequency, and duration were compared with baseline values.

A total of 34.7% patients had vitamin D insufficiency (vitamin D levels between 10 and 20 ng/mL), whereas 10.8% had vitamin D deficiency (vitamin D levels < 10 ng/mL). Migraine frequency, migraine duration, and PedMIDAS scores were significantly higher in the group 1 than group 2 (p = 0.004, p = 0.008, and p = 0.001). After vitamin D therapy at sixth months of supplementation, migraine duration was reported statistically significant shorter (p < 0.001) and the migraine frequency, VAS scores, and pedMIDAS scores were statistically significant lower compared with baseline values in group 1 (p < 0.001).

We found a marked correlation between pediatric migraine and vitamin D levels. Vitamin D therapy was beneficial in migraine pediatric patients.

Created by admin. Last Modification: Friday July 12, 2019 20:04:10 GMT-0000 by admin. (Version 9)

Attached files

ID Name Comment Uploaded Size Downloads
12309 Migraine results T5.jpg admin 12 Jul, 2019 19:39 57.92 Kb 337
12308 Migraine - child.pdf PDF 2019 admin 12 Jul, 2019 19:39 275.36 Kb 254
See any problem with this page? Report it (FINALLY WORKS)